Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials

Simple item page
dc.article.end-page10en
dc.article.start-page1en
dc.citation.doi10.1016/J.RPTH.2024.102405en
dc.contributor.authorVíctor Jimenez-Yusteen
dc.contributor.authorJohannes Oldenburgen
dc.contributor.authorEunice Tzengen
dc.contributor.authorElise Limen
dc.contributor.authorFabian Sanabriaen
dc.contributor.authorJohnny Mahlanguen
dc.date.accessioned2024-10-18T21:05:51Z
dc.date.available2024-10-18T21:05:51Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2475-0379en
dc.identifier.urihttps://hdl.handle.net/10539/41704
dc.journal.titleEmicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trialsen
dc.journal.volume8en
dc.publisherWILEY-BLACKWELLen
dc.titleEmicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trialsen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
863.85 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)